Thermo Fisher Launched Gibco CHO-K1 Media Panel
The new catalog panel helps developers optimize cell growth and protein titer for biologic production workflows.
Updated on Oct. 7, 2026 in Biotech
Thermo Fisher Scientific has launched its Gibco CHO-K1 Catalog Panel, a suite of chemically defined, animal origin-free media and feeds designed for biologics manufacturing. The product line is now available to assist upstream process development teams in scaling cell culture performance.
Why it matters
Optimizing media and feed combinations is critical for biologics developers to increase yields and meet regulatory standards. This release provides standardized, cGMP-ready tools that allow teams to rapidly identify the most efficient formulations for CHO-K1 cell lines.
In a 14-day fed-batch study using a CHO-K1 GS cell line, panel combinations demonstrated a 73% increase in titer and a 202% increase in peak viable cell density compared to industry benchmark products.
The players
Thermo Fisher Scientific
A global supplier of scientific instrumentation, reagents, and consumables for research and bioprocessing.
The details
The panel offers development teams multiple basal media—the primary nutrient solution for cell growth—and feed combinations to test for optimal expression. These formulations are chemically defined, meaning all components are known, and animal origin-free to reduce contamination risks in biologics manufacturing. Because the products are cGMP-ready, they meet current Good Manufacturing Practice standards required by regulators for substances used in clinical and commercial supply chains.
Timeline
The fed-batch study on the CHO-K1 GS cell line lasted for a duration of 14-day.
The Tech Race
The development of these media panels represents a shift toward platform-based solutions for CHO-K1 cell lines, which remain the industry standard for therapeutic protein production. This release follows a broader trend where suppliers move from custom, bespoke formulations toward standardized, ready-to-use catalog kits to accelerate bioprocess development cycles.
Biologics developers and process engineers can now access these cGMP-ready media and feed formats directly from the company's global catalog. The availability of liquid and dry powder formats allows teams to integrate these formulations into existing lab workflows without the lead times required for custom media development.
The takeaway
The move toward modular, high-performance media panels reflects a maturing bioprocess landscape that prioritizes speed and regulatory consistency. Watch for upcoming industry data on how these specific combinations perform across different bioreactor scales to confirm the titer improvements seen in initial testing.
Further reading
Explore more developments in Biotech to understand how standardized media and reagents are changing bioprocessing.
Source note: This article includes information reported by Selectscience.
